Long-term survival and health-related quality of life in patients with severe acute respiratory distress syndrome and veno-venous extracorporeal membrane oxygenation support.
Acute respiratory distress syndrome
ECMO
Extracorporeal membrane oxygenation
Long-term
Outcome
Quality of life
Survival
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
29 Nov 2021
29 Nov 2021
Historique:
received:
23
07
2021
accepted:
08
11
2021
entrez:
30
11
2021
pubmed:
1
12
2021
medline:
29
12
2021
Statut:
epublish
Résumé
There is limited information about the long-term outcome of patients suffering from acute respiratory distress syndrome (ARDS) supported with veno-venous extracorporeal membrane oxygenation (VV ECMO). Most studies focused on short- to mid-term follow-up. We aimed to investigate long-term survival and health-related quality of life (HRQL) in these patients. We report retrospective data from a single-centre registry of patients with severe ARDS treated with VV ECMO at the Interdisciplinary Medical Intensive Care Unit at the Medical Centre, University of Freiburg, Germany, between 10/2010 and 06/2019. Follow-up data of all patients that survived the index hospitalisation were collected by telephone interviews from 02/2020 till 09/2020. Long-term survival, HRQL (Short-Form Health Survey-36 (SF-36), St. Georges Respiratory Questionnaire (SGRQ), Hospital Anxiety and Depression Scale (HADS)) and the return to work rate were documented. In total, 289 patients were treated with VV ECMO during the study period (median age 55 years, 67% males, hospital survival 45%). After a median duration of 3.9 years, follow-up assessment was complete in 94 of 129 hospital survivors (73%). Fifty-three patients completed the HRQL assessment. Hospital survivors showed a high 6- and 12-month survival rate (89% and 85%, respectively). Estimated survival rate of those discharged alive from ICU was 68.5% (95%-CI 56.9-80.1%) after 9.7 years. These patients reported high levels of HRQL (median SF-36 total score 73) and only few pulmonary (median SGRQ total score 19) and mental limitations (median HAD-D score 2 and HAD-A score 3). In total, 80% of the patients were able to resume employment. This analysis of VV ECMO patients showed favourable long-term survival and high levels of HRQL suggesting promising prospects for VV ECMO survivors.
Sections du résumé
BACKGROUND
BACKGROUND
There is limited information about the long-term outcome of patients suffering from acute respiratory distress syndrome (ARDS) supported with veno-venous extracorporeal membrane oxygenation (VV ECMO). Most studies focused on short- to mid-term follow-up. We aimed to investigate long-term survival and health-related quality of life (HRQL) in these patients.
METHODS
METHODS
We report retrospective data from a single-centre registry of patients with severe ARDS treated with VV ECMO at the Interdisciplinary Medical Intensive Care Unit at the Medical Centre, University of Freiburg, Germany, between 10/2010 and 06/2019. Follow-up data of all patients that survived the index hospitalisation were collected by telephone interviews from 02/2020 till 09/2020. Long-term survival, HRQL (Short-Form Health Survey-36 (SF-36), St. Georges Respiratory Questionnaire (SGRQ), Hospital Anxiety and Depression Scale (HADS)) and the return to work rate were documented.
RESULTS
RESULTS
In total, 289 patients were treated with VV ECMO during the study period (median age 55 years, 67% males, hospital survival 45%). After a median duration of 3.9 years, follow-up assessment was complete in 94 of 129 hospital survivors (73%). Fifty-three patients completed the HRQL assessment. Hospital survivors showed a high 6- and 12-month survival rate (89% and 85%, respectively). Estimated survival rate of those discharged alive from ICU was 68.5% (95%-CI 56.9-80.1%) after 9.7 years. These patients reported high levels of HRQL (median SF-36 total score 73) and only few pulmonary (median SGRQ total score 19) and mental limitations (median HAD-D score 2 and HAD-A score 3). In total, 80% of the patients were able to resume employment.
CONCLUSION
CONCLUSIONS
This analysis of VV ECMO patients showed favourable long-term survival and high levels of HRQL suggesting promising prospects for VV ECMO survivors.
Identifiants
pubmed: 34844654
doi: 10.1186/s13054-021-03821-0
pii: 10.1186/s13054-021-03821-0
pmc: PMC8628468
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
410Informations de copyright
© 2021. The Author(s).
Références
Chin Med J (Engl). 2017 May 20;130(10):1161-1168
pubmed: 28485315
Intensive Care Med. 2013 Oct;39(10):1704-13
pubmed: 23907497
Intensive Care Med. 2006 Aug;32(8):1115-24
pubmed: 16783553
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):643-9
pubmed: 23703481
N Engl J Med. 2018 May 24;378(21):1965-1975
pubmed: 29791822
Crit Care. 2020 Jul 8;24(1):397
pubmed: 32641155
BMC Pulm Med. 2020 May 29;20(1):148
pubmed: 32471493
Heart Lung. 2016 Mar-Apr;45(2):147-53
pubmed: 26853922
J Crit Care. 2017 Feb;37:130-135
pubmed: 27718412
Lancet Respir Med. 2019 Feb;7(2):108-110
pubmed: 30642778
Intensive Care Med. 2020 Feb;46(2):182-191
pubmed: 31768569
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Ann Intensive Care. 2019 Jul 16;9(1):82
pubmed: 31312911
Lancet. 2009 Oct 17;374(9698):1351-63
pubmed: 19762075
N Engl J Med. 2003 Feb 20;348(8):683-93
pubmed: 12594312
J Psychosom Res. 2011 Aug;71(2):74-8
pubmed: 21767686
JAMA. 2017 Jan 17;317(3):290-300
pubmed: 28114553
Intensive Care Med. 2016 May;42(5):889-896
pubmed: 26942446
Am J Respir Crit Care Med. 2019 Oct 15;200(8):1002-1012
pubmed: 31144997
Intensive Care Med. 2016 May;42(5):897-907
pubmed: 27007107
JAMA. 1989 Aug 18;262(7):925-30
pubmed: 2754793
Anesthesiology. 2019 Apr;130(4):572-580
pubmed: 30875355
Intensive Care Med. 2014 Jan;40(1):74-83
pubmed: 24170143
Intensive Care Med. 2020 Nov;46(11):2048-2057
pubmed: 33021684
Lancet Respir Med. 2019 Feb;7(2):163-172
pubmed: 30642776
Am J Respir Crit Care Med. 2014 Jun 1;189(11):1374-82
pubmed: 24693864
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Artif Organs. 2021 Sep;45(9):1050-1060
pubmed: 33725377
Eur Respir J. 2002 Mar;19(3):405-13
pubmed: 11936515
Am Rev Respir Dis. 1992 Jun;145(6):1321-7
pubmed: 1595997
ASAIO J. 2020 Aug;66(8):909-914
pubmed: 32740351